What is the current stock price of Callan JMB Inc. (CJMB)?

As of the latest market data, Callan JMB Inc. (CJMB) is trading at $1.22. The stock has seen a gain of 0.83% today.

Does Callan JMB Inc. (CJMB) pay a dividend?

Based on current data, Callan JMB Inc. does not have a confirmed active dividend policy.

What is the market cap of Callan JMB Inc. ?

The current market capitalization of Callan JMB Inc. (CJMB) is approximately unavailable.

CJMB

Callan JMB Inc. ·Industrials

1.22

0.826%(+0.01)

Market Closed

1.41

15.574%(+0.19)

After Hours

Last Updated: — ET

52W L: $1.0852W H: $5.88

CJMB NEWS

globenewswire.com

4d ago

Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer

Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its Established Emergency Preparedness Network

Company Profile

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides perishable (non-pharma) client packaging, and technical services. The company was founded in 2006 and is headquartered in Spring Branch, Texas.

Sector

Industrials

Industry

Integrated Freight & Logistics

Employees

IPO Date

2025-02-06

Beta

0.90

Websitewww.coldchain-tech.com↗

CJMB

Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer

Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer

Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update

Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement

Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID

Callan JMB Inc. (CJMB) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Transcript

Callan JMB Announces Participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10–11, 2026